Request for Covid-19 Impact Assessment of this Report
Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain.
The global Gabapentin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Tablet
Capsule
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
GSK
Sailike
Jiangsu Enhua
Jiangsu Hengrui
Novartis
Actavis
Glenmark
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Nerve Pain
Restless Legs Syndrome
Seizures
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Tablet
1.2.1.2 Capsule
1.2.2 by Application
1.2.2.1 Nerve Pain
1.2.2.2 Restless Legs Syndrome
1.2.2.3 Seizures
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Tablet Market, 2011-2016
4.1.2 Capsule Market, 2011-2016
4.2 Market Forecast
4.2.1 Tablet Market Forecast, 2017-2022
4.2.2 Capsule Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Nerve Pain Market, 2011-2016
5.1.2 Restless Legs Syndrome Market, 2011-2016
5.1.3 Seizures Market, 2011-2016
5.2 Market Forecast
5.2.1 Nerve Pain Market Forecast, 2017-2022
5.2.2 Restless Legs Syndrome Market Forecast, 2017-2022
5.2.3 Seizures Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Pfizer
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 GSK
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Sailike
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Jiangsu Enhua
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Jiangsu Hengrui
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Novartis
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Actavis
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Glenmark
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
Table Products Segment of Gabapentin
Table Tablet Overview
Table Capsule Overview
Table Global Gabapentin Market by Type, 2011-2022 (USD Million)
Table Application Segment of Gabapentin
Table Nerve Pain Overview
Table Restless Legs Syndrome Overview
Table Seizures Overview
Table Global Gabapentin Market by Application, 2011-2022 (USD Million)
Table Global Gabapentin Market by Region, 2011-2022 (USD Million)
Table Cost of Gabapentin
Table Market Dynamics
Table Policy of Gabapentin
Table GDP of Major Countries
Table Tablet CAGR by Revenue and Volume, 2011-2016
Table Capsule CAGR by Revenue and Volume, 2011-2016
Table Tablet CAGR by Revenue and Volume, 2012-2022
Table Capsule CAGR by Revenue and Volume, 2012-2022
Table Nerve Pain CAGR by Revenue and Volume, 2011-2016
Table Restless Legs Syndrome CAGR by Revenue and Volume, 2011-2016
Table Seizures CAGR by Revenue and Volume, 2011-2016
Lisst Of Figures
Figure Gabapentin Picture
Figure Industry Chain Structure of Gabapentin
Figure SWOT of Gabapentin
Figure Tablet Market Size and Growth, 2011-2016 (USD Million)
Figure Tablet Market Size and Growth, 2011-2016 (in Volume)
Figure Capsule Market Size and Growth, 2011-2016 (USD Million)
Figure Capsule Market Size and Growth, 2011-2016 (in Volume)
Figure Tablet Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Tablet Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Capsule Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Capsule Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Nerve Pain Market Size and Growth, 2011-2016 (USD Million)
Figure Nerve Pain Market Size and Growth, 2011-2016 (in Volume)
Figure Restless Legs Syndrome Market Size and Growth, 2011-2016 (USD Million)
Figure Restless Legs Syndrome Market Size and Growth, 2011-2016 (in Volume)
Figure Seizures Market Size and Growth, 2011-2016 (USD Million)
Figure Seizures Market Size and Growth, 2011-2016 (in Volume)
Figure Nerve Pain Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Nerve Pain Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Seizures Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Seizures Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Gabapentin Market Concentration by Region
Figure Marketing Channels Overview
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...